SPECIAL CONSIDERATIONS IN TREATING HYPERTENSION IN THE ELDERLYGAVRAS I; GAVRAS H.1980; GERIATRICS; ISSN 0016-867X; USA; DA. 1980; VOL. 35; NO 7; PP. 34-40; 4 P.; BIBL. 2 REF.Article

The antiarrhythmic potential of angiotensin II antagonism : Experience with losartanGAVRAS, I; GAVRAS, H.American journal of hypertension. 2000, Vol 13, Num 5, pp 512-517, issn 0895-7061, 1Article

THE ANTIHYPERTENSIVE ACTION OF METHYLDOPA IN RELATION TO ITS EFFECT ON THE RENIN-ALDOSTERONE SYSTEM.GAVRAS H; GAVRAS I; BRUNNER HR et al.1977; J. CLIN. PHARMACOL.; U.S.A.; DA. 1977; VOL. 17; NO 7; PP. 372-378; BIBL. 19 REF.Article

Angiotensin inhibition and malignancies: a reviewROSENTHAL, T; GAVRAS, I.Journal of human hypertension. 2009, Vol 23, Num 10, pp 623-635, issn 0950-9240, 13 p.Article

The role of AII antagonists in hypertension : Focus on telmisartanGAVRAS, I; GAVRAS, H.Cardiovascular reviews & reports. 2000, Vol 21, Num 2, pp 76-80, issn 0197-3118Article

Angiotensin-converting enzyme inhibitors in hypertension and congestive heart failureGAVRAS, I; GAVRAS, H.Advances in internal medicine. 1990, Vol 35, pp 249-267, issn 0065-2822, 19 p.Article

ROLE OF VASOCONSTRICTOR SYSTEMS IN EXPERIMENTAL GLUCOCORTICOID-HYPERTENSION IN RATSWAEBER B; GAVRAS H; BRESNAHAN MR et al.1983; CLINICAL SCIENCE (1979); ISSN 0143-5221; GBR; DA. 1983; VOL. 65; NO 3; PP. 255-261; BIBL. 31 REF.Article

RECIPROCAL RELATION BETWEEN RENIN DEPENDENCY AND SODIUM DEPENDENCY IN ESSENTIAL HYPERTENSION.GAVRAS H; RIBEIRO AB; GAVRAS I et al.1976; NEW ENGL. J. MED.; U.S.A.; DA. 1976; VOL. 295; NO 23; PP. 1278-1283; BIBL. 26 REF.Article

ROLE OF VASOPRESSIN, CATECHOLAMINES, AND PLASMA VOLUME IN HYPERTONIC SALINE-INDUCED HYPERTENSIONHATZINIKOLAOU P; GAVRAS H; BRUNNER HR et al.1981; AM. J. PHYSIOL., HEART CIRC. PHYSIOL.; ISSN 0363-6135; USA; DA. 1981; VOL. 9; NO 6; PP. 827-831; BIBL. 12 REF.Article

BLOOD PRESSURE RESPONSE TO CENTRAL AND/OR PERIPHERAL INHIBITION OF PHENYLETHANOLAMINE N-METHYLTRANSFERASE IN NORMOTENSIVE AND HYPERTENSIVE RATSBLACK J; WAEBER B; BRESNAHAN MR et al.1981; CIRC. RES.; ISSN 0009-7330; USA; DA. 1981; VOL. 49; NO 2; PP. 518-524; BIBL. 34 REF.Article

PHYSIOLOGIC STUDIES WITH SARALASIN IN ANIMALSGAVRAS H; GAVRAS I; BRUNNER HR et al.1979; KIDNEY INTERNATION., SUPPL.; DEU; DA. 1979; NO 9; PP. 20-28; BIBL. 110 REF.Article

MALIGNANT HYPERTENSION RESULTING FROM DEOXYCORTICOSTERONE ACETATE AND SALT EXCESS. ROLE OF RENIN AND SODIUM IN VASCULAR CHANGES = HYPERTENSION MALIGNE RESULTANT DE L'ACETATE DE DESOXYCORTICOSTERONE ET D'UN EXCES DE NACL. ROLE DE LA RENINE ET DU NA DANS LES MODIFICATIONS VASCULAIRESGAVRAS H; BRUNNER HR; LARAGH JH et al.1975; CIRCUL. RES.; U.S.A.; DA. 1975; VOL. 36; NO 2; PP. 300-309; BIBL. 37REF.Article

Angiotensin II as a cardiovascular risk factorGAVRAS, I; GAVRAS, H.Journal of human hypertension. 2002, Vol 16, pp S2-S6, issn 0950-9240, SUP2Conference Paper

Effects of Eprosartan versus enalapril in hypertensive patients on the renin-angiotensin-aldosterone system and safety parameters : Results from a 26-week, double-blind, multicentre studyGAVRAS, I; GAVRAS, H.Current medical research and opinion. 1999, Vol 15, Num 1, pp 15-24, issn 0300-7995Article

Cardioprotective potential of angiotensin-converting enzyme inhibitorsGAVRAS, I; GAVRAS, H.Clinical cardiology (Mahwah, NJ). 1991, Vol 14, Num 8, pp IV.68-IV.71, issn 0160-9289, SUP4Conference Paper

Hypertensive effect of a bradykinin antagonist in normotensive ratsBENETOS, A; GAVRAS, I; GAVRAS, H et al.Hypertension (Dallas, Tex. 1979). 1986, Vol 8, Num 11, pp 1089-1092, issn 0194-911XArticle

HYPERTENSION AND AGE: CLINICAL AND BIOCHEMICAL CORRELATESGAVRAS I; GAVRAS H; CHOBANIAN AV et al.1982; CLIN. EXP. HYPERTENS., PART A, THEORY PRACT.; ISSN 504157; USA; DA. 1982; VOL. 4; NO 7; PP. 1097-1106; BIBL. 13 REF.Conference Paper

The role of vasopressin in blood pressure regulationMULINARI, R; GAVRAS, I; GAVRAS, H et al.Perspectives in hypertension series. 1989, Vol 2, pp 201-218Article

Norepinephrine applied in the paraventricular hypothalamic nucleus stimulates vasopressin releaseBENETOS, A; GAVRAS, I; GAVRAS, H et al.Brain research. 1986, Vol 381, Num 2, pp 322-326, issn 0006-8993Article

α-adrenoceptor agonists applied in the area of the nucleus tractus solitarii in the rat: effect of anesthesia on cardiovascular responsesVLAHAKOS, D; GAVRAS, I; GAVRAS, H et al.Brain research. 1985, Vol 347, Num 2, pp 372-375, issn 0006-8993Article

ORAL ANGIOTENSIN-CONVERTING ENZYME INHIBITOR IN LONG-TERM TREATMENT OF HYPERTENSIVE PATIENTSBRUNNER HR; GAVRAS H; WAEBER B et al.1979; ANN. INTERN. MED.; USA; DA. 1979; VOL. 90; NO 1; PP. 19-23; BIBL. 25 REF.Article

EFFECT OF ANGIOTENSIN CONVERTING ENZYME INHIBITION ON BLOOD PRESSURE, PLASMA RENIN ACTIVITY AND PLASMA ALDOSTERONE IN ESSENTIAL HYPERTENSION.GAVRAS H; GAVRAS I; TEXTOR S et al.1978; J. CLIN. ENDOCRINOL. METABOL.; U.S.A.; DA. 1978; VOL. 46; NO 2; PP. 220-226; BIBL. 1 P.Article

ANGIOTENSIN II INHIBITION. TREATMENT OF CONGESTIVE CARDIAC FAILURE IN A HIGH-RENIN HYPERTENSION.GAVRAS H; FLESSAS A; RYAN TJ et al.1977; J.A.M.A.; U.S.A.; DA. 1977; VOL. 238; NO 8; PP. 880-882; BIBL. 11 REF.Article

Genetic epidemiology of essential hypertensionGAVRAS, I; MANOLIS, A; GAVRAS, H et al.Journal of human hypertension. 1999, Vol 13, Num 4, pp 225-229, issn 0950-9240Article

Acylation of the N-terminus of B₂ bradykinin antagonists with bulky substituents dramatically increases potencyLAMMEK, B; ITO, Y; GAVRAS, I et al.Collection of Czechoslovak chemical communications. 1992, Vol 57, Num 9, pp 1960-1966, issn 0010-0765Article